GH Stock Analysis: Buy, Sell, or Hold?
GH - Guardant Health, Inc. Common Stock
$158.06
-2.00 (-1.25%)
▼
5d:
-6.38%
30d:
+20.93%
90d:
+101.09%
HOLD
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Jul 29, 2026
15d
Get Alerted When GH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GH shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: GH shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: GH is currently trading at $158.06, which is considered slightly high relative to its 30-day fair value range of $127.83 to $158.80.
Technical Outlook: Technically, GH is showing sideways momentum. The price is approaching resistance at $134.28. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GH is showing sideways momentum. The price is approaching resistance at $134.28. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$127.83 -
$158.80
Company Quality Score
60/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.6%
Protect Your Profits
Holding GH? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($152.54)
- CAUTION: Recommendation downgraded due to -6.4% 5-day decline
Trading Range Analysis
30-Day Trading Range
$127.83 -
$158.80
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$118.81
Resistance Level
$134.28
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-337.16
Wall Street Target
$152.54
(-4.7%)
Revenue Growth (YoY)
48.3%
Profit Margin
-40.1%
Share & Embed Analysis
Last updated: July 13, 2026 3:35 PM ET
Data refreshes hourly during market hours. Next update: 4:35 PM
Data refreshes hourly during market hours. Next update: 4:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Musa Tariq
SELL
116 shares
2026-04-16
Terilyn J Monroe
SELL
3832 shares
2026-04-06
Musa Tariq
SELL
348 shares
2026-03-18
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$591 | 64 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 67 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$271 | 54 HOLD |
|
LH
Laboratory Corporation o… |
STRONG BUY
20 analysts |
$311 | 66 BUY |
Advanced GH Option Strategies
Professional options setups generated by AI based on today's GH price and gamma walls.
